Structural basis of latent TGF-β1 presentation and activation by GARP on human regulatory T cells

Science. 2018 Nov 23;362(6417):952-956. doi: 10.1126/science.aau2909. Epub 2018 Oct 25.

Abstract

Transforming growth factor-β1 (TGF-β1) is one of very few cytokines produced in a latent form, requiring activation to exert any of its vastly diverse effects on development, immunity, and cancer. Regulatory T cells (Tregs) suppress immune cells within close proximity by activating latent TGF-β1 presented by GARP (glycoprotein A repetitions predominant) to integrin αVβ8 on their surface. We solved the crystal structure of GARP:latent TGF-β1 bound to an antibody that stabilizes the complex and blocks release of active TGF-β1. This finding reveals how GARP exploits an unusual medley of interactions, including fold complementation by the amino terminus of TGF-β1, to chaperone and orient the cytokine for binding and activation by αVβ8. Thus, this work further elucidates the mechanism of antibody-mediated blockade of TGF-β1 activation and immunosuppression by Tregs.

MeSH terms

  • Humans
  • Immune Tolerance*
  • Lymphocyte Activation
  • Membrane Proteins / chemistry*
  • Membrane Proteins / immunology
  • Protein Conformation, beta-Strand
  • Protein Folding
  • T-Lymphocytes, Regulatory / immunology*
  • Transforming Growth Factor beta1 / chemistry*
  • Transforming Growth Factor beta1 / immunology

Substances

  • LRRC32 protein, human
  • Membrane Proteins
  • TGFB1 protein, human
  • Transforming Growth Factor beta1